T. Rowe Price Associates »

Perspective Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $240k 18k 13.40
2024-06-30 $0 15k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics